Annual CAPEX
$8.84 M
-$8.09 M-47.76%
31 December 2023
Summary:
Pacific Biosciences of California annual capital expenditures is currently $8.84 million, with the most recent change of -$8.09 million (-47.76%) on 31 December 2023. During the last 3 years, it has risen by +$7.80 million (+751.11%). PACB annual CAPEX is now -47.76% below its all-time high of $16.93 million, reached on 31 December 2022.PACB CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
-$787.00 K
-$2.27 M-153.21%
30 September 2024
Summary:
Pacific Biosciences of California quarterly capital expenditures is currently -$787.00 thousand, with the most recent change of -$2.27 million (-153.21%) on 30 September 2024. Over the past year, it has dropped by -$1.62 million (-194.82%). PACB quarterly CAPEX is now -115.48% below its all-time high of $5.08 million, reached on 31 December 2022.PACB Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$6.59 M
-$1.62 M-19.69%
30 September 2024
Summary:
Pacific Biosciences of California TTM capital expenditures is currently $6.59 million, with the most recent change of -$1.62 million (-19.69%) on 30 September 2024. Over the past year, it has dropped by -$5.31 million (-44.59%). PACB TTM CAPEX is now -61.23% below its all-time high of $17.01 million, reached on 31 March 2023.PACB TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PACB CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.8% | -194.8% | -44.6% |
| 3 y3 years | +751.1% | -170.3% | +109.0% |
| 5 y5 years | +377.0% | -194.9% | +139.6% |
PACB CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -47.8% | +751.1% | -115.5% | at low | -61.2% | +109.0% |
| 5 y | 5 years | -47.8% | +751.1% | -115.5% | at low | -61.2% | +534.7% |
| alltime | all time | -47.8% | +872.8% | -115.5% | at low | -61.2% | +625.5% |
Pacific Biosciences Of California CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$787.00 K(-153.2%) | $6.59 M(-19.7%) |
| June 2024 | - | $1.48 M(-61.9%) | $8.21 M(-8.8%) |
| Mar 2024 | - | $3.88 M(+91.7%) | $9.00 M(+1.8%) |
| Dec 2023 | $8.84 M(-47.8%) | $2.02 M(+143.9%) | $8.84 M(-25.7%) |
| Sept 2023 | - | $830.00 K(-63.4%) | $11.90 M(-22.0%) |
| June 2023 | - | $2.27 M(-39.0%) | $15.26 M(-10.3%) |
| Mar 2023 | - | $3.72 M(-26.8%) | $17.01 M(+0.5%) |
| Dec 2022 | $16.93 M(+185.4%) | $5.08 M(+21.3%) | $16.93 M(+15.3%) |
| Sept 2022 | - | $4.19 M(+4.2%) | $14.69 M(+26.4%) |
| June 2022 | - | $4.02 M(+10.5%) | $11.62 M(+26.7%) |
| Mar 2022 | - | $3.64 M(+28.0%) | $9.17 M(+54.6%) |
| Dec 2021 | $5.93 M(+470.8%) | $2.84 M(+154.0%) | $5.93 M(+87.9%) |
| Sept 2021 | - | $1.12 M(-28.7%) | $3.16 M(+22.7%) |
| June 2021 | - | $1.57 M(+291.3%) | $2.57 M(+94.5%) |
| Mar 2021 | - | $401.00 K(+498.5%) | $1.32 M(+27.3%) |
| Dec 2020 | $1.04 M(-63.4%) | $67.00 K(-87.5%) | $1.04 M(-6.6%) |
| Sept 2020 | - | $536.00 K(+68.0%) | $1.11 M(-20.8%) |
| June 2020 | - | $319.00 K(+172.6%) | $1.41 M(-17.3%) |
| Mar 2020 | - | $117.00 K(-17.0%) | $1.70 M(-40.1%) |
| Dec 2019 | $2.84 M(+53.0%) | $141.00 K(-83.0%) | $2.84 M(+3.0%) |
| Sept 2019 | - | $829.00 K(+35.2%) | $2.75 M(+36.3%) |
| June 2019 | - | $613.00 K(-51.1%) | $2.02 M(-26.9%) |
| Mar 2019 | - | $1.25 M(+2060.3%) | $2.76 M(+49.0%) |
| Dec 2018 | $1.85 M(-82.2%) | $58.00 K(-39.6%) | $1.85 M(-35.1%) |
| Sept 2018 | - | $96.00 K(-92.9%) | $2.86 M(-52.5%) |
| June 2018 | - | $1.36 M(+294.2%) | $6.02 M(-25.8%) |
| Mar 2018 | - | $344.00 K(-67.5%) | $8.11 M(-22.3%) |
| Dec 2017 | $10.43 M(+27.1%) | $1.06 M(-67.5%) | $10.43 M(-13.2%) |
| Sept 2017 | - | $3.26 M(-5.5%) | $12.02 M(+8.6%) |
| June 2017 | - | $3.45 M(+29.2%) | $11.07 M(+6.2%) |
| Mar 2017 | - | $2.67 M(+0.6%) | $10.42 M(+26.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $8.21 M(+172.7%) | $2.65 M(+15.2%) | $8.21 M(+27.6%) |
| Sept 2016 | - | $2.30 M(-17.8%) | $6.43 M(+40.1%) |
| June 2016 | - | $2.80 M(+512.3%) | $4.59 M(+67.0%) |
| Mar 2016 | - | $457.00 K(-47.9%) | $2.75 M(-8.6%) |
| Dec 2015 | $3.01 M(+87.0%) | $878.00 K(+91.3%) | $3.01 M(+15.4%) |
| Sept 2015 | - | $459.00 K(-51.9%) | $2.61 M(+11.5%) |
| June 2015 | - | $955.00 K(+33.2%) | $2.34 M(+26.5%) |
| Mar 2015 | - | $717.00 K(+50.3%) | $1.85 M(+14.9%) |
| Dec 2014 | $1.61 M(+77.0%) | $477.00 K(+151.1%) | $1.61 M(+30.4%) |
| Sept 2014 | - | $190.00 K(-59.1%) | $1.23 M(-3.1%) |
| June 2014 | - | $465.00 K(-2.5%) | $1.27 M(+17.0%) |
| Mar 2014 | - | $477.00 K(+367.6%) | $1.09 M(+19.8%) |
| Dec 2013 | $909.00 K(-46.6%) | $102.00 K(-55.7%) | $909.00 K(-27.1%) |
| Sept 2013 | - | $230.00 K(-17.9%) | $1.25 M(-16.8%) |
| June 2013 | - | $280.00 K(-5.7%) | $1.50 M(-13.2%) |
| Mar 2013 | - | $297.00 K(-32.5%) | $1.73 M(+1.4%) |
| Dec 2012 | $1.70 M(-81.7%) | $440.00 K(-8.7%) | $1.70 M(-36.9%) |
| Sept 2012 | - | $482.00 K(-4.9%) | $2.70 M(-39.7%) |
| June 2012 | - | $507.00 K(+85.0%) | $4.48 M(-44.5%) |
| Mar 2012 | - | $274.00 K(-80.9%) | $8.06 M(-13.2%) |
| Dec 2011 | $9.28 M(+76.5%) | $1.44 M(-36.3%) | $9.28 M(+2.3%) |
| Sept 2011 | - | $2.26 M(-44.8%) | $9.07 M(+15.5%) |
| June 2011 | - | $4.09 M(+173.5%) | $7.86 M(+41.2%) |
| Mar 2011 | - | $1.50 M(+21.7%) | $5.56 M(+5.8%) |
| Dec 2010 | $5.26 M(+1.6%) | $1.23 M(+18.4%) | $5.26 M(+30.5%) |
| Sept 2010 | - | $1.04 M(-42.3%) | $4.03 M(+34.7%) |
| June 2010 | - | $1.80 M(+50.8%) | $2.99 M(+150.8%) |
| Mar 2010 | - | $1.19 M | $1.19 M |
| Dec 2009 | $5.18 M(-9.2%) | - | - |
| Dec 2008 | $5.70 M(+87.1%) | - | - |
| Dec 2007 | $3.05 M | - | - |
FAQ
- What is Pacific Biosciences of California annual capital expenditures?
- What is the all time high annual CAPEX for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual CAPEX year-on-year change?
- What is Pacific Biosciences of California quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly CAPEX year-on-year change?
- What is Pacific Biosciences of California TTM capital expenditures?
- What is the all time high TTM CAPEX for Pacific Biosciences of California?
- What is Pacific Biosciences of California TTM CAPEX year-on-year change?
What is Pacific Biosciences of California annual capital expenditures?
The current annual CAPEX of PACB is $8.84 M
What is the all time high annual CAPEX for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual capital expenditures is $16.93 M
What is Pacific Biosciences of California annual CAPEX year-on-year change?
Over the past year, PACB annual capital expenditures has changed by -$8.09 M (-47.76%)
What is Pacific Biosciences of California quarterly capital expenditures?
The current quarterly CAPEX of PACB is -$787.00 K
What is the all time high quarterly CAPEX for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly capital expenditures is $5.08 M
What is Pacific Biosciences of California quarterly CAPEX year-on-year change?
Over the past year, PACB quarterly capital expenditures has changed by -$1.62 M (-194.82%)
What is Pacific Biosciences of California TTM capital expenditures?
The current TTM CAPEX of PACB is $6.59 M
What is the all time high TTM CAPEX for Pacific Biosciences of California?
Pacific Biosciences of California all-time high TTM capital expenditures is $17.01 M
What is Pacific Biosciences of California TTM CAPEX year-on-year change?
Over the past year, PACB TTM capital expenditures has changed by -$5.31 M (-44.59%)